KLR Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$491K Sell
1,805
-288
-14% -$84.3K 0.35% 69
2023
Q4
$603K Buy
2,093
+312
+18% +$85K 0.44% 56
2023
Q3
$431K Buy
1,781
+50
+3% +$12.5K 0.39% 79
2023
Q2
$384K Sell
1,731
-138
-7% -$32K 0.32% 102
2023
Q1
$452K Sell
1,869
-174
-9% -$42.7K 0.4% 79
2022
Q4
$537K Buy
+2,043
New +$548K 0.44% 62

Other funds holding AMGN

KLR Investment Advisors's AMGN Position: Q1 2024 in Review

KLR Investment Advisors reduced its Amgen (AMGN) stake by 14% in Q1 2024, selling an estimated $84.3K and leaving 1,805 shares worth $491K. The position accounts for 0.35% of the portfolio, ranked #69.

KLR Investment Advisors first reported a position in AMGN in Q4 2022 and has held it in 6 quarters since. The position peaked at $603K in Q4 2023. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • KLR Investment Advisors held 1,805 shares of Amgen worth $491K as of Q1 2024.
  • KLR Investment Advisors sold 288 Amgen shares in Q1 2024, an estimated $84.3K.
  • Amgen made up 0.35% of KLR Investment Advisors's portfolio in Q1 2024, its #69 holding.
  • KLR Investment Advisors first reported a position in Amgen in Q4 2022 and has held it in 6 quarters since.
  • KLR Investment Advisors's Amgen position peaked at $603K in Q4 2023.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on KLR Investment Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.